...
机译:缺血性不可治疗心脏病患者干细胞疗法欧洲多长期研究的理由与设计(科学)
Department of CardiologyCardiologicum HamburgHamburg Germany;
Department of CardiologyCardiologicum HamburgHamburg Germany;
Advanced Heart Failure and Transplantation CenterUniversity Medical Centre LjubljanaLjubljana;
Department of Cardiology and Regenerative Medicine CenterUniversity Medical Center UtrechtUtrecht;
Department of Cardiology and Regenerative Medicine CenterUniversity Medical Center UtrechtUtrecht;
Department of Cardiology and Structural Heart DiseasesMedical University of SilesiaKatowice Poland;
Department of Cardiology and Structural Heart DiseasesMedical University of SilesiaKatowice Poland;
Department of CardiologyMedical University of ViennaVienna Austria;
Department of Cardiology and Cardiology Stem Cell CentreRigshospitalet University of;
Department of Cardiology and Cardiology Stem Cell CentreRigshospitalet University of;
Department of CardiologyAsklepios Klinik St. GeorgHamburg Germany;
Faculty of Social Sciences and the Faculty of Health SciencesUniversity of CopenhagenCopenhagen;
Department of Cardiology and Cardiology Stem Cell CentreRigshospitalet University of;
Heart failure; Adipose‐derived stromal cells; Ischaemic cardiomyopathy; Stem cells; Allogeneic therapy; Clinical trial;
机译:缺血性不可治疗心脏病患者干细胞疗法欧洲多长期研究的理由与设计(科学)
机译:“基于西洛他唑的三联抗血小板治疗对药物洗脱支架植入后缺血性并发症的影响”(CILON-T)的研究设计和原理:一项评估西洛他唑对药物洗脱后缺血性血管并发症疗效的多中心随机试验冠心病支架植入术
机译:广泛QRS和非特异性心室内传导延迟患者的心脏再同步治疗评估:多中心随机性NICD-CRT研究的原理和设计
机译:EGF和干细胞可注射共同递送的多尺度系统,用于治疗缺血性疾病
机译:第二代心脏细胞疗法:结合心脏干细胞和循环血管生成细胞治疗缺血性心脏病。
机译:欧洲缺血性非治疗性心脏疾病干细胞治疗多中心研究的原理和设计(科学)
机译:缺血性不可治疗心脏病(科学)干细胞疗法欧洲多长期研究的理由与设计